BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22198779)

  • 21. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proctitis with caecitis: an atypical presentation of ulcerative colitis.
    Hill MD; Davies G; McIntyre AS; Gorard DA
    Endoscopy; 2002 Aug; 34(8):664-6. PubMed ID: 12173090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis.
    Sinha A; Nightingale J; West KP; Berlanga-Acosta J; Playford RJ
    N Engl J Med; 2003 Jul; 349(4):350-7. PubMed ID: 12878742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical management of ulcerative proctitis, proctosigmoiditis, and left-sided colitis.
    Bitton A
    Semin Gastrointest Dis; 2001 Oct; 12(4):263-74. PubMed ID: 11726080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance and long-term prognosis of ulcerative colitis patients with appendiceal orifice inflammation.
    Kuk KW; Gwon JY; Soh JS; Lim H; Kang HS; Moon SH; Muraga A; Yoo JW
    BMC Gastroenterol; 2022 Dec; 22(1):532. PubMed ID: 36544086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.
    Garcia-Planella E; Mañosa M; Van Domselaar M; Gordillo J; Zabana Y; Cabré E; López San Román A; Domènech E
    Dig Liver Dis; 2012 Mar; 44(3):206-10. PubMed ID: 22079262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological study of colorectal cancer occurring in patients with ulcerative colitis: results from a single hospital in Japan.
    Fujita T; Ando T; Watanabe O; Hasegawa M; Miyake N; Kondo S; Kato T; Ishiguro K; Nakamura M; Miyahara R; Ohmiya N; Niwa Y; Goto H
    Hepatogastroenterology; 2010; 57(99-100):487-92. PubMed ID: 20698214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis.
    Frieri G; Pimpo M; Galletti B; Palumbo G; Corrao G; Latella G; Chiaramonte M; Caprilli R
    Dig Liver Dis; 2005 Feb; 37(2):92-6. PubMed ID: 15733520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ulcerative colitis and thrombocytopenia: a clinical case of fortuitous association?].
    Braucci S; Trappolini F; Angrisani L; Luberti E; Clarice A; Proietta M; Pisani D; Trappolini M
    Clin Ter; 2007; 158(1):27-30. PubMed ID: 17405657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.
    Hanauer S; Good LI; Goodman MW; Pizinger RJ; Strum WB; Lyss C; Haber G; Williams CN; Robinson M
    Am J Gastroenterol; 2000 Jul; 95(7):1749-54. PubMed ID: 10925979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical distribution of inflammation in newly diagnosed ulcerative colitis is not rare.
    Park SH; Yang SK; Park SK; Kim JW; Yang DH; Jung KW; Kim KJ; Ye BD; Byeon JS; Myung SJ; Kim JH
    Can J Gastroenterol Hepatol; 2014 Mar; 28(3):125-30. PubMed ID: 24619632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose mesalazine treatment for ulcerative colitis patients who relapse under low-dose maintenance therapy.
    Yamamoto T; Umegae S; Matsumoto K
    Dig Liver Dis; 2011 May; 43(5):386-90. PubMed ID: 21195041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time.
    Moum B; Ekbom A; Vatn MH; Elgjo K
    Am J Gastroenterol; 1999 Jun; 94(6):1564-9. PubMed ID: 10364026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis.
    Leifeld L; Pfützer R; Morgenstern J; Gibson PR; Marakhouski Y; Greinwald R; Mueller R; Kruis W
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1115-22. PubMed ID: 21923715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of olsalazine (dipentum) in the treatment of patients with ulcerative colitis--results of a field study.
    Singer MV; Schmausser H; Schönfeld G
    Hepatogastroenterology; 2006; 53(69):317-21. PubMed ID: 16795963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis.
    Chojnacki C; Wisniewska-Jarosinska M; Walecka-Kapica E; Klupinska G; Jaworek J; Chojnacki J
    J Physiol Pharmacol; 2011 Jun; 62(3):327-34. PubMed ID: 21893693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?).
    Ozdil S; Akyüz F; Pinarbasi B; Demir K; Karaca C; Boztas G; Kaymakoglu S; Mungan Z; Besisik F; Cakaloglu Y; Okten A
    Hepatogastroenterology; 2004; 51(57):768-70. PubMed ID: 15143912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.